. 2014 Oct 13;2014:610296. doi: 10.1155/2014/610296

Table 3.

Incidence and definition of outcome appraised in the multivariate model.

	Follow-up (months)	Definition of outcome	Incidence of outcome
Angiolillo et al., 2007 [17]	24	Cardiovascular death, ACS, and stroke	15.2 1st quartile
			12.2 2nd quartile
			12.2 3rd quartile
			37.7 4th quartile

Bliden et al., 2007 [18]	1 12	Death secondary to any cardiovascular cause, stroke, myocardial infarction (ami), and target/nontarget vessel revascularization	23 (1 month FU) 50 (12 months FU)

Breet et al., 2010 [19]	12	All-cause death, nonfatal ami, stent thrombosis, and stroke	LTA 5 11.3 (DHPR)
			8.8 (HAPR)
			10.9 (HCPR)
			4.1 (NPR)
			LTA 20 10.7 (DHPR)
			9.6 (HAPR)
			11.7 (HCPR)
			4.2 (NPR)

Buonamici et al., 2007 [2]	6	Stent thrombosis	3.1

Campo et al., 2010 [20]	12	All-cause death, nonfatal ami, and stroke	Full Responder (FR) 8.6
			Poor Responder (PR) 15.8
			ASA FR 10 PR 13
			Clop FR 5.9 PR 17.3

Chiu et al., 2011 [21]	24	Cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke	10

Collet et al., 2012 [7]	1	Stent thrombosis	2

Cuisset et al., 2006; 300 mg [22]	1	Cardiovascular death, nonfatal ami, stent thrombosis, and stroke	12
Cuisset et al., 2006; 300 mg [22]	1		33.3 HPR 0.5 NPR

Cuisset et al., 2006; 600 mg [22]	1	Cardiovascular death, nonfatal ami, stent thrombosis, and stroke	4.1
Cuisset et al., 2006; 600 mg [22]	1		27.2 HPR 0.008 NPR

Geisler et al., 2006 [23]	3	Cardiovascular death, nonfatal ami, and nonfatal stroke	6.6
			5.6 Adequate clopidogrel response
			22.7 Low clopidogrel response

Hochholzer et al., 2006 [24]	1	All-cause death, nonfatal ami, and percutaneous revascularization	1.9
Hochholzer et al., 2006 [24]	1		3.5 in upper quartile

Jin et al., 2013 [25]	12	Cardiovascular death, nonfatal ami, and nonfatal stroke	11

D.-W. Park et al., 2011 [26]	12	Cardiac death and nonfatal ami	1.4
			0.9 Adequate clopidogrel response
			2.8 Low clopidogrel response

Ko et al., 2011 [27]	1	All-cause death, nonfatal ami, nonfatal stroke, and percutaneous revascularization	8.6

Marcucci et al., 2012 [28]	12	Cardiac death and nonfatal ami	9.6

Motoda et al., 2012 [29]	12	Cardiac death, nonfatal ami, stent thrombosis, and target vessel revascularization	12
			19 in HPR
			5.1 in NPR

K. W. Park et al., 2011 [30]	24	Cardiac death, nonfatal ami, nonfatal stroke, and urgent percutaneous revascularization	14.6 HPR
K. W. Park et al., 2011 [30]	24		8.7 LPR

Park et al. (ACS), 2013 [31]	72	Cardiac death, nonfatal ami, nonfatal stroke, urgent percutaneous revascularization, and stent thrombosis

Park et al. (Stable Angina), 2013 [31]	72	Cardiac death, nonfatal ami, nonfatal stroke, urgent percutaneous revascularization, and stent thrombosis

Parodi et al., 2011 [32]	1	Cardiac death, nonfatal ami and percutaneous revascularization	3 1st quartile
			5 2nd quartile
			10 3rd quartile
			20 4th quartile

Patti et al., 2008 [33]	24	All-cause death, nonfatal ami, unstable angina, and stroke	13.3 HAPR
Patti et al., 2008 [33]	24	All-cause death, nonfatal ami, unstable angina, and stroke	9.9 LAPR

Pettersen et al., 2012 [34]	6	Cardiovascular death, nonfatal myocardial infarction, and stent thrombosis	6.5 HPR
Pettersen et al., 2012 [34]	6		1 LPR

Price et al., 2011 [9]	1	Stent thrombosis	2.2 HPR
Price et al., 2011 [9]	1	Stent thrombosis	0.2 LPR

Saia et al., 2013 [35]	12	All-cause death, ami, and urgent target vessel revascularization

Sibbing et al., 2009 [36]	1	All-cause death, ami, and urgent target vessel revascularization	Abciximab/UFH: 9.4 HPR 6.7 LPR
Sibbing et al., 2009 [36]	1		Bivalirudin: 22.0 HPR 5.0 LPR

Sibbing et al., 2012 [37]	12	Acute coronary syndrome, stent thrombosis, stroke, death, and revascularization	37.5 DHPR
			33.3 HCPR
			25.6 HAPR
			18.6 LPR

Siller-Matula et al., 2013 [38]		Acute coronary syndrome, stent thrombosis, stroke, death, and revascularization

Stone et al., 2013 [39]	24	All-cause death and myocardial infarction and stent thrombosis	2.4 death
			3.9 mi
			1.3 ST